Selecting patients for idarucizumab (Praxbind) Medicines Sponsored by Boehringer Ingelheim Pty Ltd 2 Nov 2016 In the final video of the series Professor Pollack takes us through interim results from RE-VERSE AD which identified the types of patients suitable for dabigatran reversal with idarucizumab (Praxbind).